Literature DB >> 17207856

Btk regulates multiple stages in the development and survival of B-1 cells.

Cristina M Contreras1, Kristina E Halcomb, Lindsey Randle, Rochelle M Hinman, Toni Gutierrez, Stephen H Clarke, Anne B Satterthwaite.   

Abstract

B-1 cells are important players in the first line of defense against pathogens. According to current models for the origin of B-1 cells, they either represent a separate lineage from conventional B-2 cells or differentiate from conventional B-2 cells via an intermediate, B-1(int), in response to positive selection by antigen. Here we show that Btk, a Tec family kinase that mediates B cell antigen receptor (BCR) signaling, is required at multiple stages of B-1 cell development. VH12 anti-phosphatidylcholine (PtC) IgH transgenic mice provide a model for the induced differentiation of B-1 cells. This transgene selects for PtC-reactive cells and induces them to adopt a B-1 phenotype. Both processes have been shown to depend on Btk. To determine whether this is secondary to a requirement for Btk in the development of mature B-2 cells, we crossed VH12 transgenic mice to mice expressing low levels of Btk. B-2 cell development occurs normally in Btk(lo) mice despite reduced responsiveness to BCR crosslinking. Analysis of VH12.Btk(lo) mice reveals that Btk regulates the B-1(int) to B-1 transition and/or the survival of splenic B-1 cells, in part via a mechanism independent of its role in BCR signaling. We also show that Btk mediates the survival of, and expression of IL-10 by, those B-1 cells that do develop and migrate to the peritoneum. Multiple roles for Btk in B-1 cell development and maintenance may explain the particular sensitivity of this population to mutations in components of Btk signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17207856      PMCID: PMC2567238          DOI: 10.1016/j.molimm.2006.11.023

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  50 in total

1.  Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation.

Authors:  V W Chan; F Meng; P Soriano; A L DeFranco; C A Lowell
Journal:  Immunity       Date:  1997-07       Impact factor: 31.745

2.  Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice.

Authors:  T Yoshida; K Ikuta; H Sugaya; K Maki; M Takagi; H Kanazawa; S Sunaga; T Kinashi; K Yoshimura; J Miyazaki; S Takaki; K Takatsu
Journal:  Immunity       Date:  1996-05       Impact factor: 31.745

3.  Btk dosage determines sensitivity to B cell antigen receptor cross-linking.

Authors:  A B Satterthwaite; H Cheroutre; W N Khan; P Sideras; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

Review 4.  Role of Btk in B cell development and signaling.

Authors:  S Desiderio
Journal:  Curr Opin Immunol       Date:  1997-08       Impact factor: 7.486

5.  Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation.

Authors:  A C Fluckiger; Z Li; R M Kato; M I Wahl; H D Ochs; R Longnecker; J P Kinet; O N Witte; A M Scharenberg; D J Rawlings
Journal:  EMBO J       Date:  1998-04-01       Impact factor: 11.598

6.  Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells.

Authors:  M Murakami; H Yoshioka; T Shirai; T Tsubata; T Honjo
Journal:  Int Immunol       Date:  1995-05       Impact factor: 4.823

7.  Abrogation of autoimmune disease in Lyn-deficient mice by the mutation of the Btk gene.

Authors:  H Takeshita; I Taniuchi; J Kato; T Watanabe
Journal:  Int Immunol       Date:  1998-04       Impact factor: 4.823

8.  Defective IL-5-receptor-mediated signaling in B cells of X-linked immunodeficient mice.

Authors:  M Koike; Y Kikuchi; A Tominaga; S Takaki; K Akagi; J Miyazaki; K Yamamura; K Takatsu
Journal:  Int Immunol       Date:  1995-01       Impact factor: 4.823

9.  IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses.

Authors:  M Kopf; F Brombacher; P D Hodgkin; A J Ramsay; E A Milbourne; W J Dai; K S Ovington; C A Behm; G Köhler; I G Young; K I Matthaei
Journal:  Immunity       Date:  1996-01       Impact factor: 31.745

10.  B-1 cell development: evidence for an uncommitted immunoglobulin (Ig)M+ B cell precursor in B-1 cell differentiation.

Authors:  S H Clarke; L W Arnold
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307

View more
  8 in total

1.  The ARID family transcription factor bright is required for both hematopoietic stem cell and B lineage development.

Authors:  Carol F Webb; James Bryant; Melissa Popowski; Laura Allred; Dongkoon Kim; June Harriss; Christian Schmidt; Cathrine A Miner; Kira Rose; Hwei-Ling Cheng; Courtney Griffin; Philip W Tucker
Journal:  Mol Cell Biol       Date:  2011-01-03       Impact factor: 4.272

2.  Role of B cell receptor signaling in IL-10 production by normal and malignant B-1 cells.

Authors:  Sara S Alhakeem; Vishal J Sindhava; Mary K McKenna; Beth W Gachuki; John C Byrd; Natarajan Muthusamy; Subbarao Bondada
Journal:  Ann N Y Acad Sci       Date:  2015-06-11       Impact factor: 5.691

3.  Role of Bruton's tyrosine kinase inhibitors in HIV-1-infected cells.

Authors:  Irene Guendel; Sergey Iordanskiy; Gavin C Sampey; Rachel Van Duyne; Valerie Calvert; Emanuel Petricoin; Mohammed Saifuddin; Kylene Kehn-Hall; Fatah Kashanchi
Journal:  J Neurovirol       Date:  2015-02-12       Impact factor: 2.643

4.  Transgenic mice expressing dominant-negative bright exhibit defects in B1 B cells.

Authors:  Jamee C Nixon; Scott Ferrell; Cathrine Miner; Athenia L Oldham; Ute Hochgeschwender; Carol F Webb
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

5.  Tyrosine kinase Btk is required for NK cell activation.

Authors:  Yan Bao; Jian Zheng; Chaofeng Han; Jing Jin; Huanxing Han; Yinping Liu; Yu-Lung Lau; Wenwei Tu; Xuetao Cao
Journal:  J Biol Chem       Date:  2012-05-15       Impact factor: 5.157

6.  Physical and functional characterization of the genetic locus of IBtk, an inhibitor of Bruton's tyrosine kinase: evidence for three protein isoforms of IBtk.

Authors:  Carmen Spatuzza; Marco Schiavone; Emanuela Di Salle; Elzbieta Janda; Marco Sardiello; Giuseppe Fiume; Olga Fierro; Marco Simonetta; Notis Argiriou; Raffaella Faraonio; Rosanna Capparelli; Ileana Quinto; Giuseppe Scala
Journal:  Nucleic Acids Res       Date:  2008-07-02       Impact factor: 16.971

Review 7.  Bruton's Tyrosine Kinase, a Component of B Cell Signaling Pathways, Has Multiple Roles in the Pathogenesis of Lupus.

Authors:  Anne B Satterthwaite
Journal:  Front Immunol       Date:  2018-01-22       Impact factor: 7.561

8.  Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease.

Authors:  Jasper Rip; Marjolein J W de Bruijn; Marjolein K Appelman; Simar Pal Singh; Rudi W Hendriks; Odilia B J Corneth
Journal:  Front Immunol       Date:  2019-01-30       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.